128 related articles for article (PubMed ID: 6896306)
1. Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma.
Dombernowsky P; Siegenthaler P; Somers R; Hansen HH
Eur J Cancer Clin Oncol; 1982 Jan; 18(1):71-4. PubMed ID: 6896306
[TBL] [Abstract][Full Text] [Related]
2. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
Woodcock TM; Schneider RJ; Young CW
Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
4. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
Sordillo PP; Magill GB; Gralla RJ; Kelsen DP
Am J Clin Oncol; 1982 Jun; 5(3):273-5. PubMed ID: 6896259
[TBL] [Abstract][Full Text] [Related]
5. m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
Hilgers RD; Legha SS; Panettiere FJ; Alberts DS
Am J Clin Oncol; 1983 Jun; 6(3):277-9. PubMed ID: 6687779
[TBL] [Abstract][Full Text] [Related]
6. The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II study.
Amrein PC; Poulin RF; Coleman M; Richards F; Weil M; Kennedy BJ; Carey RW; Green MR; Holland JF; Weinberg V
Am J Clin Oncol; 1984 Jun; 7(3):269-71. PubMed ID: 6547269
[TBL] [Abstract][Full Text] [Related]
7. [Phase I-II studies of a new antineoplastic agent, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA)].
Horikoshi N; Ogawa M; Inagaki J; Ezaki K; Inoue K; Okabe K; Nagata T; Aiba K; Domyo M
Gan To Kagaku Ryoho; 1982 Feb; 9(2):244-9. PubMed ID: 6897858
[TBL] [Abstract][Full Text] [Related]
8. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
Currie VE; Howard J; Wittes R
Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Van Echo DA; Markus S; Aisner J; Wiernik PH
Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
[No Abstract] [Full Text] [Related]
10. Phase II study of m-AMSA in advances malignant melanoma.
Arseneau JC; Wolter JM; Probert JC; Kuperminc M
Am J Clin Oncol; 1982 Aug; 5(4):433-6. PubMed ID: 6896795
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas.
Sternberg CN; Magill GB; Sordillo PP; Cheng E; Currie VE
Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151
[TBL] [Abstract][Full Text] [Related]
12. Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
Kearsley JH; Page JP; Levi JA; Woods RL; Tattersall MH; Fox RM; Coates AS
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):107-9. PubMed ID: 6958247
[No Abstract] [Full Text] [Related]
13. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia.
Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I
Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Ryan DH
Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
[TBL] [Abstract][Full Text] [Related]
16. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
Warrell RP; Straus DJ; Young CW
Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
Cheng E; Lightdale C; Young C; Yagoda A; Fortner J; Golbey R
Am J Clin Oncol; 1983 Apr; 6(2):211-3. PubMed ID: 6299095
[No Abstract] [Full Text] [Related]
18. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
[No Abstract] [Full Text] [Related]
19. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny N; Lynch G; Wookcock T
Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
[No Abstract] [Full Text] [Related]
20. A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies.
Brenner DE; Garbino C; Kasdorf H; Villasanta U; Polcaro R; Yovarone J; Aisner J; Schiffer CA; Wiernik PH
Am J Clin Oncol; 1982 Jun; 5(3):291-5. PubMed ID: 6896260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
